TABLE 2.

Bacteria and viruses detected through culture, multiplexed PCRs, or serology in patients with a sore throat and in controls

	Percent (number of patients)
	Patients	Controls	Fisher or χ2 testa
	(n = 220)	(n = 128)	p
GAS	30 (66)	2.3 (3)	<0.001a
GCS	3.6 (8)	0.8 (1)	0.16
GGS	3.2 (7)	7.0 (9)	0.10a
Fusobacterium necrophorum	15.0 (33)	3.1 (4)	0.001a
Chlamydophila pneumoniae	0	0	—
Mycoplasma pneumoniae	1.8 (4)	0.8 (1)	0.66
Adenovirus	4.1 (9)	1.6 (2)	0.34
Bocavirus	0.5 (1)	0.8 (1)	1.0
Coronavirus NL63	1.8 (4)	0	0.30
Coronavirus OC43	1.8 (4)	0	0.30
Coronavirus HKU1	0.9 (2)	1.6 (2)	0.63
Coronavirus 229E	1.4 (3)	0.8 (1)	1.0
EBV	5 (2.3)	NA	—
Enterovirus	0.5 (1)	0.8 (1)	1.0
Influenza A virus	1.8 (4)	0	0.30
Influenza B virus	7.3 (16)	0	0.002a
Metapneumovirus	1.8 (4)	0	0.30
Parainfluenzavirus	0.5 (1)	0	1.0
Rhinovirus	6.4 (14)	2.3 (3)	0.09a
RSV	1.8 (4)	1.6 (2)	1.0

GAS, Group A streptococci; GCS, Group C streptococci; GGS, Group G streptococci; EBV, Epstein-Barr virus; RSV, respiratory syncytial virus.

Statistical analyses were calculated using χ² test or Fisher's exact test.

^aχ² test was used.